At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy. (Q45935288)
Jump to navigation
Jump to search
scientific article published on 7 July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy. |
scientific article published on 7 July 2009 |
Statements
1 reference
At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy. (English)
1 reference
Ian Hamilton-Craig
1 reference
Karam Kostner
1 reference
David Colquhoun
1 reference
Stan Woodhouse
1 reference
7 July 2009
1 reference
18
1 reference
5
1 reference
343-346
1 reference